Inequitable Conduct Claim Nixed In Seroquel Suit
Sandoz Inc. and Teva Pharmaceutical Industries Ltd. have lost their bid to render the patent for AstraZeneca Pharmaceuticals LP's popular anti-psychotic drug Seroquel unenforceable, eliminating the need for a trial in...To view the full article, register now.
Already a subscriber? Click here to view full article